posted on 2012-07-25, 00:00authored byJohannes
G. Beck, Jayanta Chatterjee, Burkhardt Laufer, Marelli Udaya Kiran, Andreas O. Frank, Stefanie Neubauer, Oded Ovadia, Sarit Greenberg, Chaim Gilon, Amnon Hoffman, Horst Kessler
Insufficient oral bioavailability is considered as a
key limitation
for the widespread development of peptides as therapeutics. While
the oral bioavailability of small organic compounds is often estimated
from simple rules, similar rules do not apply to peptides, and even
the high oral bioavailability that is described for a small number
of peptides is not well understood. Here we present two highly Caco-2
permeable template structures based on a library of 54 cyclo(-d-Ala-Ala5-) peptides with different N-methylation patterns. The first (all-trans) template
structure possesses two β-turns of type II along Ala6-d-Ala1 and Ala3-Ala4 and
is only found for one peptide with two N-methyl groups
at d-Ala1 and Ala6 [(NMe(1,6)]. The second (single-cis) template possesses a characteristic cis peptide bond preceding Ala5, which results in type VI
β-turn geometry along Ala4-Ala5. Although
the second template structure is found in seven peptides carrying N-methyl groups on Ala5, high Caco-2 permeability
is only found for a subgroup of two of them [NMe(1,5) and NMe(1,2,4,5)], suggesting that N-methylation
of d-Ala1 is a prerequisite for high permeability
of the second template structure. The structural similarity of the
second template structure with the orally bioavailable somatostatin
analog cyclo(-Pro-Phe-NMe-d-Trp-NMe-Lys-Thr-NMe-Phe-), and the striking
resemblance with both β-turns of the orally bioavailable peptide
cyclosporine A, suggests that the introduction of bioactive sequences
on the highly Caco-2 permeable templates may result in potent orally
bioavailable drug candidates.